Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

2010 Prevention: “Cancer Prevention Among Women” Teleconference

November 9, 2010 10:36 am | by AACR | News | Comments

Moderated by Judy Garber, M.D., M.P.H., president-elect of the American Association for Cancer Research and leader of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute

TOPICS:

Prevention 2010: Interview with Avrum E. Spira, M.D., M.Sc.

November 9, 2010 10:34 am | by AACR | News | Comments

Interview with Avrum E. Spira, M.D., M.Sc., chief, division of computational biomedicine and director of the translational bioinformatics program at Boston University’s Clinical and Translational Science Institute

TOPICS:

Emeritus 5M-share offering priced at $18.25 each

November 9, 2010 9:45 am | by The Associated Press | News | Comments

Emeritus Corp. said Tuesday an underwritten public offering of 5 million of its shares was priced at $18.25 each.The company plans to sell 4 million shares, while shareholders will sell 1 million shares. Emeritus will not receive any proceeds from the sale of shares by shareholders.Emeritus has...

Advertisement

Study shows durable viral suppression of boosted REYATAZ in treatment-experienced HIV patients

November 9, 2010 9:36 am | by EurekAlert | News | Comments

(TogoRun) Results from a European Observational Study, which included 1,294 antiretroviral-experienced patients presented today at the Tenth International Congress on Drug Therapy in HIV Infection, demonstrated a low rate of discontinuation and sustained virologic suppression with...

TOPICS:

Portable microwave sensors for measuring vital signs

November 9, 2010 9:36 am | by EurekAlert | News | Comments

(American Institute of Physics) Current medical techniques for monitoring the heart rate and other vital signs use electrodes attached to the body, which are impractical for patients who want to move around. Plasma physicist Atsushi Mase, a scientist at Kyushu University in Japan,...

TOPICS:

Synageva lands orphan drug status in Europe

November 9, 2010 9:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Synageva BioPharma Corp. has won orphan drug status from the European Medicines Agency (EMA) for its enzyme replacement therapy, SBC-102, to treat Lysosomal Acid Lipase Deficiency.

MLSC opens second round of life sciences grant program

November 9, 2010 9:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The Massachusetts Life Sciences Center is accepting applications for its Cooperative Research Matching Grant Program, intended to help move scientific research from universities and research institutions into commercialized products.

Accuray shares fall on 1Q results

November 9, 2010 8:45 am | by The Associated Press | News | Comments

Shares of medical radiation equipment maker Accuray Inc. fell Tuesday after the company said it fiscal 2011 first-quarter loss widened on a drop in revenue.The stock fell 62 cents, or 9.2 percent, to $6.15 in afternoon trading Tuesday. Shares have traded between $4.93 and $7.75 over the last 52...

Advertisement

Prevention 2010: Interview with Kathryn L. Taylor, Ph.D.

November 9, 2010 8:32 am | by AACR | News | Comments

Prevention 2010: Interview with Kathryn L. Taylor, Ph.D., associate professor at Georgetown’s Lombardi Comprehensive Cancer Center

TOPICS:

Bradford Barton Named President, ConvaTec U.S.

November 9, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

SKILLMAN, N.J., Nov. 9, 2010 /- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the appointment of Bradford (Brad) Barton as President, ConvaTec U.S.   Based in Skillman, NJ, Barton will lead the...

TOPICS:

FDA Working to Prevent Radiation Overdoses During CT Scans

November 9, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Nov. 9, 2010 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. The FDA found that when properly used, the...

TOPICS:

Menopausal Hormone Therapy May Increase Risk of Ovarian Cancer

November 9, 2010 7:33 am | by AACR | News | Comments

PHILADELPHIA — Women planning on taking hormone therapy for the treatment of menopausal symptoms should be aware of a possible increased risk for ovarian cancer, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.

TOPICS:

Side Effects of Hormonal Breast Cancer Therapy Increased; May Affect Treatment Adherence

November 9, 2010 7:33 am | by AACR | News | Comments

PHILADELPHIA — Women being treated for breast cancer with aromatase inhibitors may experience extremely low estrogen levels resulting in a wide variety of side effects that a typical postmenopausal woman without cancer may not experience.

TOPICS:

Exercise May Reduce Risk of Endometrial Cancer

November 9, 2010 7:33 am | by AACR | News | Comments

PHILADELPHIA — Women who exercise for 150 minutes a week or more may see a reduced risk of endometrial cancer, despite whether or not they are overweight, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.

TOPICS:

Alere to Attend the Lazard Capital Markets 7th Annual Healthcare Conference on November 17, 2010

November 9, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., Nov. 9, 2010 /- Alere Inc. (NYSE: ALR ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the Lazard Capital Markets 7th Annual Healthcare...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading